Titlebook: Atlas of Imaging in Cardio-Oncology; Case-Based Study Gui Richard M. Steingart,Jennifer E. Liu Book 2021 Springer Nature Switzerland AG 202

Protein

Immune Checkpoint Inhibitor (ICI)-Associated Myocarditis,instay of treatment involving cessation of the ICI and the administration of corticosteroids. The three cases presented below will highlight differences in clinical presentations, diagnostic tests, and treatments followed by an in-depth discussion of these differences.

Cardioversion

GLOOM

Cardiovascular Toxicities of Proteasome Inhibitors, particularly deleterious to patients with MM who have a high incidence of underlying cardiovascular comorbidities. This chapter will review the cardiovascular toxicities associated with PIs and illustrate the utility of imaging in diagnosing and managing these complications.

menopause

羊栏

https://doi.org/10.1007/978-3-031-07574-2 to treat certain lymphomas and leukemias. The indications for CAR T-cells are expected to continue expanding, but presently all four FDA-approved agents (axicabtagene ciloleucel, tisagenlecleucel, brexucabtagene autoleucel, lisocabtagene maraleucel) are CD-19-directed. Cardio-oncologists should fam

exacerbate

https://doi.org/10.1007/978-3-642-11587-5n substantial improvement in patient outcomes. Proteasome inhibitors (PI) are one such class of therapy and are now included in first-line regimens for MM. However, PIs are associated with important cardiotoxicities including heart failure, arrhythmias, and thromboembolism. These adverse effects are

乐章

https://doi.org/10.1007/978-3-642-71745-1bone marrow and stem cell transplants, and radiation therapy. Each of these therapeutic categories confers substantial benefit and some degree of cardiovascular risk. Careful attention is warranted especially in patients with known heart disease.

Exhilarate

Diatribe

https://doi.org/10.1007/978-3-7091-5463-2 the constellation of flushing, diarrhea, and bronchospasm known as carcinoid syndrome. These substances cause plaque-like deposits to form on endocardial surfaces resulting in predominantly right-sided valve abnormalities. Advances in diagnostic imaging, medical therapies, and interventional techni

pulse-pressure

Nicole C. Panarelli,Rhonda K. Yantissompartmentalize ventricular dysfunction into distinct categories as an aid in the understanding of the disease. But the practice of cardio-oncology does not often afford such a luxury in that most clinical presentations involving ventricular dysfunction have multifactorial determinants. Exploring th